Hims & Hers Health (HIMS) Cash & Current Investments (2019 - 2026)

Hims & Hers Health (HIMS) reported Cash & Current Investments of $750.9 million for Q1 2026, up 132.71% on a YoY basis from $322.7 million in Q1 2025, and up 30.02% sequentially from $577.5 million in Q4 2025.

Hims & Hers Health (HIMS) Cash & Current Investments (2019 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 8 years of Cash & Current Investments data on file, last reported at $750.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments rose 132.71% year-over-year to $750.9 million; the trailing twelve-month figure through Mar 2026 stood at $750.9 million (up 132.71% YoY), and the FY2025 full-year result was $577.5 million, up 92.34% from the prior year.
  • Cash & Current Investments improved to $750.9 million in Q1 2026, from $577.5 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $1.1 billion in Q2 2025 to a low of $179.6 million in Q4 2022.
  • A 5-year average of $352.8 million and a median of $221.0 million in 2023 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments tumbled 38.56% in 2022 and soared 403.59% in 2025, its largest moves.
  • Tracing HIMS's Cash & Current Investments over 5 years: stood at $179.6 million in 2022, then increased by 23.02% to $221.0 million in 2023, then surged by 35.87% to $300.3 million in 2024, then soared by 92.34% to $577.5 million in 2025, then surged by 30.02% to $750.9 million in 2026.
  • Business Quant data shows HIMS's Cash & Current Investments at $750.9 million in Q1 2026, $577.5 million in Q4 2025, and $629.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 3.74 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 428.00 Mn
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn 750.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 750.88 Mn
Dec 31, 2025 577.49 Mn
Sep 30, 2025 629.74 Mn
Jun 30, 2025 1.14 Bn
Mar 31, 2025 322.67 Mn
Dec 31, 2024 300.25 Mn
Sep 30, 2024 254.07 Mn
Jun 30, 2024 227.29 Mn
Mar 31, 2024 203.59 Mn
Dec 31, 2023 220.98 Mn
Sep 30, 2023 212.50 Mn
Jun 30, 2023 193.14 Mn
Mar 31, 2023 184.39 Mn
Dec 31, 2022 179.63 Mn
Sep 30, 2022 198.39 Mn
Jun 30, 2022 194.98 Mn
Mar 31, 2022 203.05 Mn
Dec 31, 2021 247.27 Mn
Sep 30, 2021 252.43 Mn
Jun 30, 2021 317.32 Mn